ClinicalTrials.gg
RecruitingNCT05164172REJOINUpdated Oct 14, 2026

A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

A Phase 3 interventional study of Eptinezumab in Migraine, sponsored by H. Lundbeck A/S. Recruiting at 64 sites in 11 countries. Open to participants aged 6 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by H. Lundbeck A/S · Phase 3, Interventional, and Treatment

From the registry’s dates

  • Started Dec 2021; still recruiting 4 years 11 months later.
Updated Oct 14, 202656 sites added62 sites removedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
600
Allocation
Randomized
Ages
6 Years to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 21 studies testing eptinezumab in Migraine Disorders — 6 open to participants now, 6 under way, 5 of them phase 3. eptinezumab · Migraine Disorders.

Planned enrollment
7th of 21
600 · median 193
Started
2021
with 4 others
Phase 3
13 of 21
5 open now
Registered
14th of 21
by date
Lead sponsor
12 of 21
H. Lundbeck A/S

Among the 21 studies testing eptinezumab in Migraine Disorders, this one is the 7th largest by planned enrollment, is one of 5 that started in 2021, is one of 13 in phase 3, and was the 14th registered.

Migraine Disorders

1,658 studies on the registry are indexed under Migraine Disorders; 340 are open to participants now.

Browse Migraine Disorders studies →

Open to participants now

6 of the 21 studies testing eptinezumab in Migraine Disorders are open now, in 11 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

About eptinezumab

eptinezumab: first FDA approval 2020 (VYEPTI), first EMA approval 2022. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 217 Migraine Disorders studies recruiting now, 66 (30%) set no upper age limit and 136 (63%) stop at 75 or younger; 44 take children under 18; 37 take healthy volunteers.

This study: 6 Years to 17 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies testing eptinezumab in Migraine Disorders, or all of them as a file.
02

Study summary

The main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migraine.

Read the detailed description

This is an extension study for participants aged 6 to 17 with migraine who completed either studies 19356A (NCT04965675) (chronic migraine [CM] study in adolescents) or 19357A (episodic migraine [EM] study in children and adolescents). All participants who complete the Week 12 visit of the respective lead-in study will be offered participation in this open-label extension (OLE) study, unless there is a safety concern precluding a participant's participation in the study. Participants originally randomized to 100 milligrams (mg) (weight adjusted) in the double-blind lead-in study (Study 19356A or Study 19357A) will continue on the same dose (100 mg, weight adjusted) in the OLE study. Participants randomized to the 300 mg dose (weight adjusted) in the double-blind lead-in study will continue on 300 mg (weight adjusted) in the OLE study. Participants who were assigned to placebo in the double-blind lead-in study will be randomly allocated to one of the two treatment groups: eptinezumab 100 mg (weight adjusted) or eptinezumab 300 mg (weight adjusted) with a ratio of 1:1.

03

Conditions studied

  • Migraine

Browse trials for

04

Who can participate

Ages eligible
6 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- The participant must have completed Week12 (completion) visit of either Study19356A (CM) or Study19357A (EM) immediately prior to enrolment into this OLE study.

Exclusion criteria

Exclusion Criteria:

  • The participant has an adverse event or other safety concerns that are deemed related to double-blind treatment received in the lead-in study and is considered a potential safety risk by the investigator.
  • During lead-in Study19356A or Study19357A:
  • participant experienced ananaphylactic reaction or another severe and/or serious reaction to the medicinal product (IMP) infusion, as assessed by the investigator
  • the participant had a serum (ALT) or aspartate aminotransferase(AST) value >5 times the upper limit of the reference range that was confirmed by testing \<2 weeks later.
  • the participant had a serum ALT or AST value >3times the upper limit of the reference range and a serum total value >2times the upper limit of the reference range.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

ALT and AST (liver enzymes)

Two enzymes measured in a routine blood test of the liver. Higher levels can mean the liver is under strain or damaged. SGPT and SGOT are older names for ALT and AST.

Criteria usually give a limit as a multiple of the upper limit of normal (ULN), often higher when cancer has spread to the liver.

Bilirubin

A yellow substance made when red blood cells are broken down, which the liver clears. A high level can mean a problem with the liver or the bile ducts.

Criteria often allow more for people with Gilbert’s syndrome, a harmless inherited condition that raises bilirubin.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
600 participants (estimated)

Study arms

  • Experimental
    Eptinezumab 300 mg

    Participants will receive 3 intravenous (IV) infusions of eptinezumab 300 mg (weight adjusted) at Weeks 0, 12, and 24.

    Drug: Eptinezumab

  • Experimental
    Eptinezumab 100 mg

    Participants will receive 3 IV infusions of eptinezumab 100 mg (weight adjusted) at Weeks 0, 12, and 24.

    Drug: Eptinezumab

Interventions

  • Concentrate for solution for infusion

    Also known as: Vyepti

06

What researchers measure

Primary outcomes

  1. Number of Participants With Treatment Emergent Adverse Events

    Time frame: Baseline up to Week 44

Secondary outcomes

  1. Free Eptinezumab Plasma Concentration

    Time frame: Baseline, Weeks 8, 12, 24, 36, and 44

  2. Number of Participants With Specific Anti-Eptinezumab Antibodies (Anti-Drug Antibodies [ADA])

    Time frame: Baseline (Week 0), Weeks 8, 12, 24, 36, and 44

  3. Number of Participants With Specific Anti-Eptinezumab Antibodies for Neutralizing Activity (NAb)

    Time frame: Baseline (Week 0), Weeks 8, 12, 24, 36, and 44

  4. Change From Baseline in Pediatric Migraine Disability Assessment Questionnaire (PedMIDAS) Score at Weeks 12, 24, and 36

    Time frame: Baseline, Weeks 12, 24, and 36

07

Study locations

54 of 64 sites recruiting
  • Yale School of Medicine - The Scirex Clinical Research Unit
    New Haven, Connecticut 06519-1405, United States
    Recruiting
  • New England Institute for Clinical Research (NEICR) - Stamford
    Stamford, Connecticut 06905-1206, United States
    Recruiting
  • Sarkis Clinical Trials - Gainsville
    Gainesville, Florida 32607, United States
    Completed

    Not enrolling at this site — choose another above.

  • NW FL Clinical Research Group, LLC
    Gulf Breeze, Florida 32561-4495, United States
    Recruiting
  • AGA Clinical Trials
    Hialeah, Florida 33012-3407, United States
    Recruiting
  • Axcess Medical Research - Loxahatchee
    Loxahatchee Groves, Florida 33470-9206, United States
    Completed

    Not enrolling at this site — choose another above.

  • University of South Florida (USF) - Tampa Campus
    Tampa, Florida 33620, United States
    Recruiting
  • University of Kentucky (UK) - Markey Cancer Center
    Lexington, Kentucky 40536-0002, United States
    Recruiting
  • University of Maryland School of Medicine
    Baltimore, Maryland 21201-1509, United States
    Recruiting
  • Michigan Headache & Neurological Institute (MHNI)
    Ann Arbor, Michigan 48104-5131, United States
    Completed

    Not enrolling at this site — choose another above.

  • Corewell Health - Helen DeVos Children's Hospital (HDVCH) - Medical Genetics
    Grand Rapids, Michigan 49503, United States
    Completed

    Not enrolling at this site — choose another above.

  • Dent Neurosciences Research Center
    Amherst, New York 14226-1727, United States
    Completed

    Not enrolling at this site — choose another above.

  • True North Neurology - Commack (North Suffolk Neurology)
    Commack, New York 11725-2850, United States
    Recruiting
  • OnSite Clinical Solutions, LLC - Charlotte
    Charlotte, North Carolina 28210-0106, United States
    Completed

    Not enrolling at this site — choose another above.

  • Akron Children's Hospital
    Akron, Ohio 44308-1062, United States
    Recruiting
  • Cincinnati Children's Hospital Medical Center-Burnet Campus
    Cincinnati, Ohio 45229-3026, United States
    Recruiting
  • Road Runner Research (RRR)
    San Antonio, Texas 78249-3539, United States
    Recruiting
  • Children's Specialty Group (CSG)
    Norfolk, Virginia 23510, United States
    Recruiting
  • Marshall Health-Marshall University Medical Center
    Huntington, West Virginia 25701-3656, United States
    Recruiting
  • Children's Wisconsin (Children's Hospital of Wisconsin)-Main Campus
    Milwaukee, Wisconsin 53226, United States
    Recruiting
  • Hospital Privado de Comunidad (HPC)
    Mar del Plata, Buenos Aires B7602CBM, Argentina
    Completed

    Not enrolling at this site — choose another above.

  • Mautalén Salud e Investigación
    Buenos Aires, Buenos Aires F.D. C1128AAF, Argentina
    Completed

    Not enrolling at this site — choose another above.

  • Hospital de Niños de la Santísima Trinidad
    Córdoba, Córdoba Province X5014AKM, Argentina
    Recruiting
  • Instituto Médico Río Cuarto
    Río Cuarto, Córdoba Province 5800, Argentina
    Recruiting
  • INECO Neurociencias Oroño
    Rosario, Santa Fe Province S2000DTP, Argentina
    Recruiting
  • Centro de Investigaciones Medicas Tucuman
    San Miguel de Tucumán, Tucumán Province T4000AXL, Argentina
    Recruiting
  • Vancouver Island Health Authority (VIHA) - Multiple Sclerosis (MS) Clinic
    Victoria, British Columbia V8R 1J8, Canada
    Recruiting
  • Kids Clinic
    Ajax, Ontario L1Z 0M1, Canada
    Recruiting
  • London Health Sciences Centre (LHSC)
    London, Ontario N6A 5W9, Canada
    Recruiting
  • L'Azienda Ospedaliera Brotzu - Clinica di Neuropsichiatria dell'Infanzia e dell'Adolescenza - Ret...
    Cagliari, South Sardinia 09121, Italy
    Completed

    Not enrolling at this site — choose another above.

  • Istituto Giannina Gaslini IRCCS
    Genoa, 16147, Italy
    Recruiting
  • Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
    Milan, 20133, Italy
    Completed

    Not enrolling at this site — choose another above.

  • Fondazione Mondino, IRCCS Istituto Neurologico Nazionale a Carattere Scientifico
    Pavia, 27100, Italy
    Recruiting
  • Azienda Ospedaliero Universitaria Pisana - Stabilimento Ospedaliero di Santa Chiara - Istituto To...
    Pisa, 56126, Italy
    Recruiting
  • Ospedale Pediatrico Bambino Gesu - Gianicolo
    Rome, 00165, Italy
    Recruiting
  • Instituto de Investigaciones Clinicas para la Salud A.C. (IICS A.C)
    Durango, Durango 34000, Mexico
    Recruiting
  • Centro de Investigacion Medico Biologica y Terapia Avanzada S.C. (CIMBYTA)
    Guadalajara, Jalisco 44130, Mexico
    Recruiting
  • Clinical Research Institute SC-Mexico
    Tepetlacalco, State of Mexico 54055, Mexico
    Recruiting
  • ICARO Investigaciones en Medicina, S.A de C.V
    Chihuahua City, 31000, Mexico
    Recruiting
  • Centrum Medyczne Plejady
    Krakow, Lesser Poland Voivodeship 30-363, Poland
    Recruiting
  • Instytut Zdrowia dr Boczarska-Jedynak Sp. z o.o. Sp. k
    Oświęcim, Lesser Poland Voivodeship 32-600, Poland
    Recruiting
  • ETG Lublin
    Lublin, Lublin Voivodeship 20-412, Poland
    Recruiting
  • MTZ Clinical Research Powered by PRATIA
    Warsaw, Masovian Voivodeship 02-172, Poland
    Recruiting
  • European Trial group network Sp. z o.o - Neuroscience
    Warsaw, Masovian Voivodeship 02-677, Poland
    Recruiting
  • Unidade Local de Saude de Almada-Seixal E.P.E. (ULSAS)
    Almada, Setúbal District 2805-267, Portugal
    Recruiting
  • Hospital de Braga
    Braga, 4710-367, Portugal
    Recruiting
  • Hospital Pediátrico de Coimbra
    Coimbra, 3000-602, Portugal
    Recruiting
  • Centro Hospitalar Universitario de Santo Antonio - Centro Materno Infantil do Norte (CMIN)
    Porto, 4050, Portugal
    Recruiting
  • Centro Hospitalar Universitario de Sao Joao (CHUSJ)
    Porto, 4200-319, Portugal
    Recruiting
  • Univerzitetska Decija Klinika (UDK) (University Children's Hospital)
    Belgrade, Beograd 11000, Serbia
    Recruiting
  • University of Novi Sad - Faculty of Medicine - Clinical Center of Vojvodina - Hematology Clinic
    Novi Sad, Juznobacki Okrug 21000, Serbia
    Recruiting
  • Institute of Child and Youth Health Care of Vojvodina
    Novi Sad, Juznobacki Okrug 21101, Serbia
    Recruiting
  • Clinical Center Kragujevac
    Kragujevac, Sumadijski Okrug 34000, Serbia
    Recruiting
  • University Clinical Center Nis
    Niš, 18 000, Serbia
    Recruiting
  • Hospital Universitario Virgen del Rocio (HUVR)
    Seville, Seville 41013, Spain
    Recruiting
  • Hospital Universitari Vall d'Hebron
    Barcelona, 08035, Spain
    Recruiting
  • Hospital Clinico San Carlos
    Madrid, 28040, Spain
    Recruiting
  • Eskisehir Osmangazi Universitesi Tip Fakultesi Hastanesi (Eskisehir Osmangazi University Hospital)
    Eskişehir, 26480, Turkey (Türkiye)
    Recruiting
  • İzmir Şehir Hastanesi
    Izmir, 35540, Turkey (Türkiye)
    Recruiting
  • Mersin Universitesi-Tip Fakultesi
    Mersin, 33343, Turkey (Türkiye)
    Recruiting
  • NHS Lothian - Royal Hospital for Children & Young People (RHCYP)
    Edinburgh, Eastern Scotland EH16 4TJ, United Kingdom
    Recruiting
  • James Paget University Hospitals NHS Foundation Trust
    Great Yarmouth, Norfolk NR31 6LA, United Kingdom
    Recruiting
  • NHS Greater Glasgow and Clyde-Glasgow Clinical Research Facility - Queen Elizabeth University Hos...
    Glasgow, South Western Scotland G51 4TF, United Kingdom
    Recruiting
  • Great Ormond Street Hospital for Children NHS Foundation Trust
    London, WC1N 3JH, United Kingdom
    Recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2021 (actual). Primary completion is estimated for Apr 2028, 76 months after the start.

Of 114 industry-sponsored phase 3 interventional studies under Migraine Disorders, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 31. This study's planned 76 months is above that.

Counting every sponsor, half of 140 studies reached it within 19 months; a quarter within 12 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 7, 2021
First posted
Dec 20, 2021
StartActual
Dec 1, 2021
Primary completionEst.
Apr 30, 2028
CompletionEst.
Apr 30, 2028
Last update
Oct 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
56 sites added, 62 sites removed
Show 56 added (18 United States, 6 Italy, 5 Poland, 5 Portugal, 4 Argentina, 4 Serbia, 3 Canada, 3 Mexico, 3 Turkey (Türkiye), 3 United Kingdom, 2 Spain)
  • Yale School of Medicine - The Scirex Clinical Research Unit · New Haven, United States
  • New England Institute for Clinical Research (NEICR) - Stamford · Stamford, United States
  • Sarkis Clinical Trials - Gainsville · Gainesville, United States
  • AGA Clinical Trials · Hialeah, United States
  • Axcess Medical Research - Loxahatchee · Loxahatchee Groves, United States
  • University of South Florida (USF) - Tampa Campus · Tampa, United States
  • University of Kentucky (UK) - Markey Cancer Center · Lexington, United States
  • Michigan Headache & Neurological Institute (MHNI) · Ann Arbor, United States
  • Corewell Health - Helen DeVos Children's Hospital (HDVCH) - Medical Genetics · Grand Rapids, United States
  • Dent Neurosciences Research Center · Amherst, United States
  • True North Neurology - Commack (North Suffolk Neurology) · Commack, United States
  • OnSite Clinical Solutions, LLC - Charlotte · Charlotte, United States
  • Akron Children's Hospital · Akron, United States
  • Cincinnati Children's Hospital Medical Center-Burnet Campus · Cincinnati, United States
  • Road Runner Research (RRR) · San Antonio, United States
  • Children's Specialty Group (CSG) · Norfolk, United States
  • Marshall Health-Marshall University Medical Center · Huntington, United States
  • Children's Wisconsin (Children's Hospital of Wisconsin)-Main Campus · Milwaukee, United States
  • Hospital Privado de Comunidad (HPC) · Mar del Plata, Argentina
  • Mautalén Salud e Investigación · Buenos Aires, Argentina
  • Hospital de Niños de la Santísima Trinidad · Córdoba, Argentina
  • Centro de Investigaciones Medicas Tucuman · San Miguel de Tucumán, Argentina
  • Vancouver Island Health Authority (VIHA) - Multiple Sclerosis (MS) Clinic · Victoria, Canada
  • Kids Clinic · Ajax, Canada
  • London Health Sciences Centre (LHSC) · London, Canada
  • L'Azienda Ospedaliera Brotzu - Clinica di Neuropsichiatria dell'Infanzia e dell'Adolescenza - Ret... · Cagliari, Italy
  • Istituto Giannina Gaslini IRCCS · Genoa, Italy
  • Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Milan, Italy
  • Fondazione Mondino, IRCCS Istituto Neurologico Nazionale a Carattere Scientifico · Pavia, Italy
  • Azienda Ospedaliero Universitaria Pisana - Stabilimento Ospedaliero di Santa Chiara - Istituto To... · Pisa, Italy
  • …and 26 more on the registry record
Show 62 removed
  • Yale University School of Medicine · New Haven, United States
  • Ki Health Partners LLC DBA New England Institute for Clinical Research · Stamford, United States
  • AGA Clinical Trials - Hialeah - 4980 W 10th Ave · Hialeah, United States
  • Axcess Medical Research · Loxahatchee Groves, United States
  • University of South Florida · Tampa, United States
  • University of Kentucky · Lexington, United States
  • Michigan Head Pain and Neurological Institute · Ann Arbor, United States
  • Michigan State University - Department of Neurology · East Lansing, United States
  • Helen Devos Childrens' Hospital - PIN · Grand Rapids, United States
  • Dent Neurosciences Research Center Incorporated · Amherst, United States
  • True North Neurology · Commack, United States
  • OnSite Clinical Solutions, LLC - Randolph Rd - Charlotte · Charlotte, United States
  • Childrens Hospital Medical Center of Akron · Akron, United States
  • Cincinnati Children's Hospital Medical Center - PIN · Cincinnati, United States
  • Road Runner Research Ltd · San Antonio, United States
  • Children's Specialty Group - 3 Commercial Place · Norfolk, United States
  • Marshall University Medical Center · Huntington, United States
  • Children's Wisconsin - Milwaukee Campus - PIN · Milwaukee, United States
  • Hospital Privado de La Comunidad · Mar del Plata, Argentina
  • Hospital de Niños de La Santisima Trinidad · Córdoba-Barrio Crisol, Argentina
  • Centro de Investigaciones Médicas Tucumán - PPDS · San Miguel de Tucumán, Argentina
  • Expertia S.A- Mautalén Salud e Investigación · Buenos Aires, Argentina
  • Vancouver Island Health Authority · Victoria, Canada
  • The Kids Clinic · Ajax, Canada
  • London Health Sciences Centre -800 Commissioners Rd E · London, Canada
  • IRCCS Ospedale Pediatrico Bambino Gesu · Rome, Italy
  • IRCCS Istituto Giannina Gaslini · Genoa, Italy
  • Ospedale San Raffaele S.r.l. · Milan, Italy
  • Fondazione IRCCS Istituto Neurologico Carlo Besta · Milan, Italy
  • AO Brotzu - Clinica di Neuropsichiatria dell'Infanzia e dell'Adolescenza · Cagliari, Italy
  • …and 32 more on the registry record
Oct 14, 2026
Show all 1 update
  1. Oct 14, 2026
    56 sites added, 62 sites removed
    Show 56 added (18 United States, 6 Italy, 5 Poland, 5 Portugal, 4 Argentina, 4 Serbia, 3 Canada, 3 Mexico, 3 Turkey (Türkiye), 3 United Kingdom, 2 Spain)
    • Yale School of Medicine - The Scirex Clinical Research Unit · New Haven, United States
    • New England Institute for Clinical Research (NEICR) - Stamford · Stamford, United States
    • Sarkis Clinical Trials - Gainsville · Gainesville, United States
    • AGA Clinical Trials · Hialeah, United States
    • Axcess Medical Research - Loxahatchee · Loxahatchee Groves, United States
    • University of South Florida (USF) - Tampa Campus · Tampa, United States
    • University of Kentucky (UK) - Markey Cancer Center · Lexington, United States
    • Michigan Headache & Neurological Institute (MHNI) · Ann Arbor, United States
    • Corewell Health - Helen DeVos Children's Hospital (HDVCH) - Medical Genetics · Grand Rapids, United States
    • Dent Neurosciences Research Center · Amherst, United States
    • True North Neurology - Commack (North Suffolk Neurology) · Commack, United States
    • OnSite Clinical Solutions, LLC - Charlotte · Charlotte, United States
    • Akron Children's Hospital · Akron, United States
    • Cincinnati Children's Hospital Medical Center-Burnet Campus · Cincinnati, United States
    • Road Runner Research (RRR) · San Antonio, United States
    • Children's Specialty Group (CSG) · Norfolk, United States
    • Marshall Health-Marshall University Medical Center · Huntington, United States
    • Children's Wisconsin (Children's Hospital of Wisconsin)-Main Campus · Milwaukee, United States
    • Hospital Privado de Comunidad (HPC) · Mar del Plata, Argentina
    • Mautalén Salud e Investigación · Buenos Aires, Argentina
    • Hospital de Niños de la Santísima Trinidad · Córdoba, Argentina
    • Centro de Investigaciones Medicas Tucuman · San Miguel de Tucumán, Argentina
    • Vancouver Island Health Authority (VIHA) - Multiple Sclerosis (MS) Clinic · Victoria, Canada
    • Kids Clinic · Ajax, Canada
    • London Health Sciences Centre (LHSC) · London, Canada
    • L'Azienda Ospedaliera Brotzu - Clinica di Neuropsichiatria dell'Infanzia e dell'Adolescenza - Ret... · Cagliari, Italy
    • Istituto Giannina Gaslini IRCCS · Genoa, Italy
    • Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Milan, Italy
    • Fondazione Mondino, IRCCS Istituto Neurologico Nazionale a Carattere Scientifico · Pavia, Italy
    • Azienda Ospedaliero Universitaria Pisana - Stabilimento Ospedaliero di Santa Chiara - Istituto To... · Pisa, Italy
    • …and 26 more on the registry record
    Show 62 removed
    • Yale University School of Medicine · New Haven, United States
    • Ki Health Partners LLC DBA New England Institute for Clinical Research · Stamford, United States
    • AGA Clinical Trials - Hialeah - 4980 W 10th Ave · Hialeah, United States
    • Axcess Medical Research · Loxahatchee Groves, United States
    • University of South Florida · Tampa, United States
    • University of Kentucky · Lexington, United States
    • Michigan Head Pain and Neurological Institute · Ann Arbor, United States
    • Michigan State University - Department of Neurology · East Lansing, United States
    • Helen Devos Childrens' Hospital - PIN · Grand Rapids, United States
    • Dent Neurosciences Research Center Incorporated · Amherst, United States
    • True North Neurology · Commack, United States
    • OnSite Clinical Solutions, LLC - Randolph Rd - Charlotte · Charlotte, United States
    • Childrens Hospital Medical Center of Akron · Akron, United States
    • Cincinnati Children's Hospital Medical Center - PIN · Cincinnati, United States
    • Road Runner Research Ltd · San Antonio, United States
    • Children's Specialty Group - 3 Commercial Place · Norfolk, United States
    • Marshall University Medical Center · Huntington, United States
    • Children's Wisconsin - Milwaukee Campus - PIN · Milwaukee, United States
    • Hospital Privado de La Comunidad · Mar del Plata, Argentina
    • Hospital de Niños de La Santisima Trinidad · Córdoba-Barrio Crisol, Argentina
    • Centro de Investigaciones Médicas Tucumán - PPDS · San Miguel de Tucumán, Argentina
    • Expertia S.A- Mautalén Salud e Investigación · Buenos Aires, Argentina
    • Vancouver Island Health Authority · Victoria, Canada
    • The Kids Clinic · Ajax, Canada
    • London Health Sciences Centre -800 Commissioners Rd E · London, Canada
    • IRCCS Ospedale Pediatrico Bambino Gesu · Rome, Italy
    • IRCCS Istituto Giannina Gaslini · Genoa, Italy
    • Ospedale San Raffaele S.r.l. · Milan, Italy
    • Fondazione IRCCS Istituto Neurologico Carlo Besta · Milan, Italy
    • AO Brotzu - Clinica di Neuropsichiatria dell'Infanzia e dell'Adolescenza · Cagliari, Italy
    • …and 32 more on the registry record
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT05164172
Lead sponsor
H. Lundbeck A/S
Responsible party
Sponsor
First posted
Dec 20, 2021
Start date
Dec 1, 2021
Primary completion
Apr 30, 2028 (estimated)
Completion
Apr 30, 2028 (estimated)
Last update
Oct 14, 2026

Study contacts

Email contact via H. Lundbeck A/S
Contact
HQ_Medinfo@Lundbeck.com
+45 36301311
Email contact via H. Lundbeck A/S
study director · H. Lundbeck A/S

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Eptinezumab

Start the discussion